BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Tyrosine kinase non-receptor 2 (Tnk2; ACK1)

March 5, 2015 8:00 AM UTC

In vitro studies have identified an aminopyrimidine ACK1 inhibitor that could help treat cancer. In the human prostate cancer cell line LNCaP and the highly metastatic prostate cancer cell line VCaP, ...